Clinical Trials Sponsored by Epitech Mag Ltd.

Total 107 results

Epitech Mag Ltd.

Terminated

Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease (OMNS)

Dry Eye Syndromes | Sjogren's Syndrome | ATD

Israel
Epitech Mag Ltd.

Completed

Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye

Dry Eye | Dry Eye Syndromes | Sjogren's Syndrome | Meibomian Gland Dysfunction | Aqueous Tear Deficiency

Israel
Peritech Pharma Ltd.

Completed

A Prospective, Randomized, Three Arms, Open Label Study Comparing the Safety and Efficacy of Two Formulations of PP110 to the Active Comparator Preparation-H® Cream in the Treatment of Bleeding Hemorrhoids Grades 2-3

Bleeding Hemorrhoids

Israel
CHA MEDITECH Co., Ltd.

Completed

Clinical Study to CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement

Penile Enhancement | Small Penis

Korea, Republic of
Asieris MediTech (Hong Kong) Co., Ltd.

Active, not recruiting

Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL) (APRICITY)

Cervical Intraepithelial Neoplasia Grade 2/3

China
Scitech Produtos Medicos Ltda

Not yet recruiting

The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion (DEScover)

Chronic Renal Failure | Venous Stenosis | Venous Occlusion
Scitech Produtos Medicos Ltda

Recruiting

Observational Study of ALTUS Powered Stapler Used in Bariatric Surgery

Obesity

Brazil
Scitech Produtos Medicos Ltda

Completed

OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation (Laranjeiras)

Coronary Artery Disease

Brazil
Scitech Produtos Medicos Ltda

Completed

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent (CRONUS)

Coronary Artery Disease

Brazil
Scitech Produtos Medicos Ltda

Active, not recruiting

Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent (Inspiron RL II)

Coronary Artery Disease

Brazil
Scitech Produtos Medicos Ltda

Completed

SOLARIS Endoprosthesis in Iliac Occlusive Disease (SOLARIS I)

Peripheral Arterial Disease

Brazil
Scitech Produtos Medicos Ltda

Completed

DESTINY TRIAL (Inspiron x Biomatrix)

Coronary Artery Disease

Brazil
Scitech Produtos Medicos Ltda

Withdrawn

A Clinical Study to Evaluate the Safety and Performance of the Modular AAA Stent-Graft System (Stent-Graft)

Cardiovascular Diseases | Abdominal Aortic Aneurysm

Brazil
Scitech Produtos Medicos Ltda

Completed

Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE (LATITUDE)

Coronary Artery Disease

Brazil
Scitech Produtos Medicos Ltda

Completed

Serial OCT Evaluation of Tissue Coverage in Patients Submitted to Inspiron Drug Eluting Stent Implantation (REPAIR)

Coronary Artery Disease

Brazil
Scitech Produtos Medicos Ltda

Completed

Uterine Artery Embolization With Microspheres in Patients With Leiomyoma. (EMBOSOFT I)

Uterine Leiomyoma

Brazil
Scitech Produtos Medicos Ltda

Unknown

INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique (insProvisional)

Coronary Artery Disease | Bifurcation Lesion

Brazil
Scitech Produtos Medicos Ltda

Completed

MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions (MAGIC-TOUCH)

Coronary Artery Disease

Brazil
Scitech Produtos Medicos Ltda

Completed

A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus (INSPIRON)

Coronary Artery Disease

Brazil
Suzhou Zenith Vascular Scitech Co., Ltd.

Completed

A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke

Acute Ischemic Stroke | Large Vessel Occlusion | AIS | Thrombectomy

China
Suzhou Zenith Vascular Scitech Co., Ltd.

Not yet recruiting

Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME) (SRAME)

PE - Pulmonary Embolism | PE - Pulmonary Thromboembolism

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers

Bladder Cancer

Australia
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis

United States
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer (ANTICIPATE)

Muscle Invasive Bladder Cancer

United States, China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients (ASCERTAIN)

Non-muscle Invasive Bladder Cancer

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Active, not recruiting

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients (ACCRUE)

Non-muscle Invasive Bladder Cancer

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Completed

Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy

Non-muscle Invasive Bladder Cancer
Tritech Biopharmaceuticals Co., Ltd.
A2 Healthcare Taiwan Corporation

Unknown

A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients

Erectile Dysfunction

Taiwan
Suzhou Zenith Vascular Scitech Co., Ltd.
Xuanwu Hospital, Beijing

Recruiting

Timing Carotid Stent Clinical Study for the Treatment of Carotid Artery Stenosis（Timing Trial）

Stroke | Ischemic Stroke | Carotid Artery Diseases | Carotid Artery Stenosis

China
Fuda Cancer Hospital, Guangzhou
Shanghai Asclepius Meditech Co., Ltd

Completed

Hydrogen Gas for Cancer Rehabilitation

Adult Solid Tumor

China
Asieris Pharmaceuticals (AUS) Pty Ltd.

Completed

A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets

Bladder Cancer

Australia
Max Biocare Pty. Ltd.

Completed

Tregocel® as a Dietary Supplement in Mild Knee Osteoarthritis

Mild Knee Osteoarthritis

Poland
Photocure
Jiangsu Yahong Meditech Co., Ltd aka Asieris; Richard Wolf GmbH; Tigermed-Jyton...

Completed

Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer

Bladder Cancer

China
I-Mab Biopharma Co. Ltd.

Recruiting

Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors

Gastric Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Esophageal Adenocarcinoma | Gastroesophageal Junction Carcinoma

United States, China
I-Mab Biopharma Co. Ltd.

Recruiting

A Study of TJ003234 in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

China
I-Mab Biopharma Co. Ltd.

Completed

Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors

Solid Tumor | Metastatic Cancer | Advanced Cancer

United States
I-Mab Biopharma Co. Ltd.

Recruiting

A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
I-Mab Biopharma Co. Ltd.

Completed

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 COVID-19

United States
I-Mab Biopharma Co. Ltd.

No longer available

Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001

Solid Tumor Metastatic Cancer Advanced Cancer
I-Mab Biopharma Co. Ltd.

Completed

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects

Healthy Adult Subjects

United States
AbbVie
I-Mab Biopharma Co. Ltd.

Completed

Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma

Lymphoma | Solid Tumor

United States, China
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases

Breast Cancer
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Assessment of TK006 in Patients With Breast Cancer-related Bone Metastases

Breast Cancer

China
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Assessment of Anti-RANKL Antibody in Post-menopausal Women

Osteoporosis

China
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

A Study of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-Related Macular Degeneration

China
Jiangsu T-Mab Biopharma Co.,Ltd

Completed

Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects

Chemotherapy-induced Neutropenia

China
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer

Chemotherapy-induced Neutropenia

China
Jiangsu T-Mab Biopharma Co.,Ltd

Completed

Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors

Chemotherapy-induced Neutropenia | Metastatic Tumors

China
LifeScan Scotland Ltd
MAC Clinical Research

Completed

Clinical Evaluation of LifeScan Blood Glucose Monitoring Systems

Diabetes Mellitus

United Kingdom
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration

China

3

Subscribe